XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
  Parkinson's
   Rotenone
  Dementia
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Aug 19th, 2006 - 22:18:38

Rotenone Channel
subscribe to Rotenone newsletter

Latest Research : Aging : Parkinson's : Rotenone

   DISCUSS   |   EMAIL   |   PRINT
How rotenone destroys the dopamine neurons
Aug 25, 2005, 05:20, Reviewed by: Dr. Ankush Vidyarthi

"Based on these findings, we believe that microtubules are a critical target of PD environmental toxins such as rotenone"

 
Neuroscientists from the University at Buffalo have described for the first time how rotenone, an environmental toxin linked specifically to Parkinson's disease, selectively destroys the neurons that produce dopamine, the neurotransmitter critical to body movement and muscle control.

Microtubules, intracellular highways that transport dopamine to the brain area that controls body movement, are the crucial target, they report.

Damage to microtubules prevents dopamine from reaching the brain's movement center, causing a back-up of the neurotransmitter in the transport system, the researchers found. The backed-up dopamine accumulates in the body of the neuron and breaks down, causing a release of toxic free radicals, which destroy the neuron.

The study appeared in the Aug. 9 issue of the Journal of Biological Chemistry.

"This study shows how an environmental toxin affects the survival of dopamine neurons by targeting microtubules that are critical for the survival of dopamine-producing neurons," said Jian Feng, Ph.D., assistant professor of physiology and biophysics in the UB School of Medicine and Biomedical Sciences and senior author on the study.

"Based on these findings, we have identified several ways to stabilize microtubules against the onslaught of rotenone. These results ultimately may lead to novel therapies for Parkinson's disease."

At least 500,000 people are believed to suffer from Parkinson's disease in the United States, and about 50,000 new cases are reported annually, according to the National Institutes of Health. These figures are expected to increase as the population ages: The average age of onset is about 60. The disorder appears to be slightly more common in men than women.

Feng and colleagues in the Department of Physiology and Biophysics have concentrated their research on the cellular mechanisms of the disease. They are interested specifically in understanding why rotenone destroys neurons that produce dopamine, while sparing neurons that produce other neurotransmitters.

Using cultures of rat neurons, the researches subjected neurons that produce various types of neurotransmitters to agents that mimic the action of rotenone. These results showed that dopaminergic neurons were destroyed while others survived.

They then topped off the treatment by adding the drug taxol, which stabilizes microtubules and prevents their breakdown. Findings showed that by protecting microtubules, the toxic effect of rotenone on dopamine-producing neurons was greatly reduced.

"Based on these findings, we believe that microtubules are a critical target of PD environmental toxins such as rotenone," said Feng. "Since many microtubule-depolymerizing agents are compounds naturally produced in many plants, our research points to the need to examine their possible link to Parkinson's disease. In addition, PD has a higher incidence in rural areas and is associated with pesticides and insecticides frequently used in farming practices."

The research also opens up novel avenues for the development of PD therapies by targeting microtubules, he said. Feng and colleagues in his laboratory are working actively towards this goal.
 

- The study appeared in the Aug. 9 issue of the Journal of Biological Chemistry.
 

University at Buffalo

 
Subscribe to Rotenone Newsletter
E-mail Address:

 

Additional researchers on the study were Yong Ren, Ph.D., Wenhau Liu, Ph.D., Houbo Jiang, Ph.D., and Qian Jiang, Ph.D., post-doctoral associates in the Department of Physiology and Biophysics.

The research is funded by a grant from the National Institutes of Health.

The University at Buffalo is a premier research-intensive public university, the largest and most comprehensive campus in the State University of New York.


Related Rotenone News

Stabilizing microtubules with L-AP4 reduces rotenone toxicity
How rotenone destroys the dopamine neurons


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us